Tag
Canopy Growth Corp
- Canadian cannabis industry added C$16B to nation's GDP last year
- Surprise surprise, new study finds that cannabis makes music more enjoyable
- Canopy reduces workforce by 8% to save up to $150 million
- Canopy launches behind the scenes video series on flower production
- Acreage boosts annual sales 65% to US$188.9M
- Canopy's BioSteel to sell in 15K more stores across US
- Canopy scant on equity metrics in first ESG report
- Canopy's BioSteel signs 4‑year partnership with Athletics Canada
- Acreage gets US$150M credit facility
- Canopy selling German subsidiary for up to $180M, losing nearly half of purchase price
- Canopy CFO and CPO step down from board
- Indiva holds top spot in edibles category despite 15% revenue drop
- Canopy buys right to acquire Wana for US$297.5M
- TREC Brands set to buy Agripharm for undisclosed sum
- Canopy's BioSteel now official drink of LA Lakers
- Hexo to buy 48North Cannabis for $50M
- Aurora stock falls amid more large losses and cost cuts
- Organigram drops CEO shortly after big tobacco investment
- Valens enters US CBD market with purchase of Florida firm
- Canadian pot production slows as supply eases to 1.1B grams
- Canopy links up with major US alcohol distributor
- Canopy buying Supreme Cannabis for $435M in premium brand grab
- Can you buy brand loyalty? Canopy thinks so
- BC grower becomes Canada's first licensed producer to unionize
- Local industry relieved as province halts sale of Cannabis NB
- Hexo touts Q2 earnings, eyes M&A
- Tokyo Smoke workers latest in cannabis industry to unionize
- Organigram shares surge on big tobacco deal
- Reddit traders send pot stocks to the moon ‑‑ and back
- Canopy shares surge on 2022 profit prediction
- Canopy, Curaleaf, advocacy groups join forces to advance US cannabis reform
- Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B
- Martha Stewart and Canopy Growth release CBD dog treats — but are they safe?
- Ontario set to be first province to launch farmgate sales this year
- Aphria stock hits 2‑year high on record Q2 sales
- Hexo, Molson Coors launch first US CBD drinks in Colorado
- US FDA unveils plan to gather 'real-world' data to fill CBD research gaps
- Canopy's GW Pharma lawsuit could be trouble for US extractors
- Canopy Growth inks $297M deal to give up stake in Canopy Rivers
- Canopy shutters 5 Canadian facilities, beverage boss walks
- Ontario speeds up cannabis retail approvals again amid applicant frustration
- Alberta's regulator leads country in enforcement transparency
- Worm study shows CBD may extend life
- Why the Georgia Senate runoff could reshape North America's cannabis sector
- Canopy celebrates rising Canadian sales and Biden win
- Talking pain and cannabis with Canopy's head of medicine: Q&A
- Analyst lukewarm on Aphria's US$300M SweetWater acquisition
- Pot stock leaders to consider ahead of US election: BCMI
- Slang Worldwide expands into Canada, targets BC vape market
- New York will legalize weed by April, governor advisor says